A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session38dda512ebbb20cff6cc0577ef477243de1a1e13): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Vaccine Contract Manufacturing Market Research Report 2024

img

Global Vaccine Contract Manufacturing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Vaccine Contract Manufacturing Market Research Report 2024

According to MRAResearch’s new survey, global Vaccine Contract Manufacturing market is projected to reach US$ 2558.5 million in 2033, increasing from US$ 1731.5 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vaccine Contract Manufacturing market research.
Key companies engaged in the Vaccine Contract Manufacturing industry include Diosynth, Emergent BioSolutions, Goodwin Biotechnology, Bavarian Nordic, Soligenix Inc and Catalent Biologics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Vaccine Contract Manufacturing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Vaccine Contract Manufacturing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Vaccine Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Segment by Type
Fill-Finish
Bulk Product

Segment by Application


Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Vaccine Contract Manufacturing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Fill-Finish
1.2.3 Bulk Product
1.3 Market by Application
1.3.1 Global Vaccine Contract Manufacturing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Contract Manufacturing Market Perspective (2018-2033)
2.2 Vaccine Contract Manufacturing Growth Trends by Region
2.2.1 Global Vaccine Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Vaccine Contract Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Region (2024-2033)
2.3 Vaccine Contract Manufacturing Market Dynamics
2.3.1 Vaccine Contract Manufacturing Industry Trends
2.3.2 Vaccine Contract Manufacturing Market Drivers
2.3.3 Vaccine Contract Manufacturing Market Challenges
2.3.4 Vaccine Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2022
3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Vaccine Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Contract Manufacturing Breakdown Data by Type
4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2024-2033)
5 Vaccine Contract Manufacturing Breakdown Data by Application
5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Vaccine Contract Manufacturing Market Size (2018-2033)
6.2 North America Vaccine Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Vaccine Contract Manufacturing Market Size by Country (2018-2023)
6.4 North America Vaccine Contract Manufacturing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Contract Manufacturing Market Size (2018-2033)
7.2 Europe Vaccine Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Vaccine Contract Manufacturing Market Size by Country (2018-2023)
7.4 Europe Vaccine Contract Manufacturing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2018-2033)
8.2 Asia-Pacific Vaccine Contract Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2018-2023)
8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Contract Manufacturing Market Size (2018-2033)
9.2 Latin America Vaccine Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Vaccine Contract Manufacturing Market Size by Country (2018-2023)
9.4 Latin America Vaccine Contract Manufacturing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2018-2033)
10.2 Middle East & Africa Vaccine Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2018-2023)
10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diosynth
11.1.1 Diosynth Company Detail
11.1.2 Diosynth Business Overview
11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2018-2023)
11.1.5 Diosynth Recent Development
11.2 Emergent BioSolutions
11.2.1 Emergent BioSolutions Company Detail
11.2.2 Emergent BioSolutions Business Overview
11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2018-2023)
11.2.5 Emergent BioSolutions Recent Development
11.3 Goodwin Biotechnology
11.3.1 Goodwin Biotechnology Company Detail
11.3.2 Goodwin Biotechnology Business Overview
11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2018-2023)
11.3.5 Goodwin Biotechnology Recent Development
11.4 Bavarian Nordic
11.4.1 Bavarian Nordic Company Detail
11.4.2 Bavarian Nordic Business Overview
11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2018-2023)
11.4.5 Bavarian Nordic Recent Development
11.5 Soligenix Inc
11.5.1 Soligenix Inc Company Detail
11.5.2 Soligenix Inc Business Overview
11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2018-2023)
11.5.5 Soligenix Inc Recent Development
11.6 Catalent Biologics
11.6.1 Catalent Biologics Company Detail
11.6.2 Catalent Biologics Business Overview
11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2018-2023)
11.6.5 Catalent Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Fill-Finish
Table 3. Key Players of Bulk Product
Table 4. Global Vaccine Contract Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Vaccine Contract Manufacturing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Vaccine Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Vaccine Contract Manufacturing Market Share by Region (2018-2023)
Table 8. Global Vaccine Contract Manufacturing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Vaccine Contract Manufacturing Market Share by Region (2024-2033)
Table 10. Vaccine Contract Manufacturing Market Trends
Table 11. Vaccine Contract Manufacturing Market Drivers
Table 12. Vaccine Contract Manufacturing Market Challenges
Table 13. Vaccine Contract Manufacturing Market Restraints
Table 14. Global Vaccine Contract Manufacturing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Vaccine Contract Manufacturing Market Share by Players (2018-2023)
Table 16. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2022)
Table 17. Ranking of Global Top Vaccine Contract Manufacturing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Vaccine Contract Manufacturing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vaccine Contract Manufacturing Product Solution and Service
Table 21. Date of Enter into Vaccine Contract Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vaccine Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2018-2023)
Table 25. Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2024-2033)
Table 27. Global Vaccine Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2018-2023)
Table 29. Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2024-2033)
Table 31. North America Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Vaccine Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Vaccine Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Vaccine Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Vaccine Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Vaccine Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Vaccine Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Vaccine Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Diosynth Company Detail
Table 47. Diosynth Business Overview
Table 48. Diosynth Vaccine Contract Manufacturing Product
Table 49. Diosynth Revenue in Vaccine Contract Manufacturing Business (2018-2023) & (US$ Million)
Table 50. Diosynth Recent Development
Table 51. Emergent BioSolutions Company Detail
Table 52. Emergent BioSolutions Business Overview
Table 53. Emergent BioSolutions Vaccine Contract Manufacturing Product
Table 54. Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2018-2023) & (US$ Million)
Table 55. Emergent BioSolutions Recent Development
Table 56. Goodwin Biotechnology Company Detail
Table 57. Goodwin Biotechnology Business Overview
Table 58. Goodwin Biotechnology Vaccine Contract Manufacturing Product
Table 59. Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2018-2023) & (US$ Million)
Table 60. Goodwin Biotechnology Recent Development
Table 61. Bavarian Nordic Company Detail
Table 62. Bavarian Nordic Business Overview
Table 63. Bavarian Nordic Vaccine Contract Manufacturing Product
Table 64. Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2018-2023) & (US$ Million)
Table 65. Bavarian Nordic Recent Development
Table 66. Soligenix Inc Company Detail
Table 67. Soligenix Inc Business Overview
Table 68. Soligenix Inc Vaccine Contract Manufacturing Product
Table 69. Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2018-2023) & (US$ Million)
Table 70. Soligenix Inc Recent Development
Table 71. Catalent Biologics Company Detail
Table 72. Catalent Biologics Business Overview
Table 73. Catalent Biologics Vaccine Contract Manufacturing Product
Table 74. Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2018-2023) & (US$ Million)
Table 75. Catalent Biologics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Vaccine Contract Manufacturing Market Share by Type: 2022 VS 2033
Figure 3. Fill-Finish Features
Figure 4. Bulk Product Features
Figure 5. Global Vaccine Contract Manufacturing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Vaccine Contract Manufacturing Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Biotech Companies Case Studies
Figure 9. Others Case Studies
Figure 10. Vaccine Contract Manufacturing Report Years Considered
Figure 11. Global Vaccine Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Vaccine Contract Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Vaccine Contract Manufacturing Market Share by Region: 2022 VS 2033
Figure 14. Global Vaccine Contract Manufacturing Market Share by Players in 2022
Figure 15. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2022
Figure 17. North America Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Vaccine Contract Manufacturing Market Share by Country (2018-2033)
Figure 19. United States Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Vaccine Contract Manufacturing Market Share by Country (2018-2033)
Figure 23. Germany Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Vaccine Contract Manufacturing Market Share by Region (2018-2033)
Figure 31. China Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Vaccine Contract Manufacturing Market Share by Country (2018-2033)
Figure 39. Mexico Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Vaccine Contract Manufacturing Market Share by Country (2018-2033)
Figure 43. Turkey Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Vaccine Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Diosynth Revenue Growth Rate in Vaccine Contract Manufacturing Business (2018-2023)
Figure 46. Emergent BioSolutions Revenue Growth Rate in Vaccine Contract Manufacturing Business (2018-2023)
Figure 47. Goodwin Biotechnology Revenue Growth Rate in Vaccine Contract Manufacturing Business (2018-2023)
Figure 48. Bavarian Nordic Revenue Growth Rate in Vaccine Contract Manufacturing Business (2018-2023)
Figure 49. Soligenix Inc Revenue Growth Rate in Vaccine Contract Manufacturing Business (2018-2023)
Figure 50. Catalent Biologics Revenue Growth Rate in Vaccine Contract Manufacturing Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed